- Home
- SVMH vs QNRX Comparison
SVMH vs QNRX Comparison
Compare SVMH & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVMH
- QNRX
- Stock Information
- Founded
- SVMH 2018
- QNRX 2018
- Country
- SVMH Cayman Islands
- QNRX United States
- Employees
- SVMH N/A
- QNRX N/A
- Industry
- SVMH
- QNRX Medical/Dental Instruments
- Sector
- SVMH
- QNRX Health Care
- Exchange
- SVMH Nasdaq
- QNRX Nasdaq
- Market Cap
- SVMH 3.1M
- QNRX 3.0M
- IPO Year
- SVMH N/A
- QNRX N/A
- Fundamental
- Price
- SVMH $0.03
- QNRX $0.56
- Analyst Decision
- SVMH
- QNRX Strong Buy
- Analyst Count
- SVMH 0
- QNRX 1
- Target Price
- SVMH N/A
- QNRX $4.00
- AVG Volume (30 Days)
- SVMH 108.1M
- QNRX 2.7M
- Earning Date
- SVMH 12-31-2024
- QNRX 11-07-2024
- Dividend Yield
- SVMH N/A
- QNRX N/A
- EPS Growth
- SVMH N/A
- QNRX N/A
- EPS
- SVMH N/A
- QNRX N/A
- Revenue
- SVMH $42,538.00
- QNRX N/A
- Revenue This Year
- SVMH N/A
- QNRX N/A
- Revenue Next Year
- SVMH N/A
- QNRX N/A
- P/E Ratio
- SVMH N/A
- QNRX N/A
- Revenue Growth
- SVMH N/A
- QNRX N/A
- 52 Week Low
- SVMH $0.02
- QNRX $0.48
- 52 Week High
- SVMH $0.48
- QNRX $6.18
- Technical
- Relative Strength Index (RSI)
- SVMH 47.14
- QNRX 38.41
- Support Level
- SVMH $0.03
- QNRX $0.72
- Resistance Level
- SVMH $0.03
- QNRX $0.87
- Average True Range (ATR)
- SVMH 0.01
- QNRX 0.15
- MACD
- SVMH 0.00
- QNRX -0.02
- Stochastic Oscillator
- SVMH 31.85
- QNRX 3.81
About SVMH SRIVARU Holding Limited
SRIVARU Holding Ltd focuses to revolutionize two-wheeled vehicles (TWV) by developing products powered by renewable energy, which are assured for safety, performance, and comfort, thereby providing safe riding experience to its customers. It operates in one reportable segment which is vehicle manufacturing. SVH's first product line, the Prana, is a E2W vehicle that is redefining the category. SVH has commenced engineering and design work for the Prana-Elite that is expected to leverage the same platform as the Prana-Grand, while upgrading its range.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.